Category: THE CELLVIEW

India has one of the largest proportions of population in the younger age groups in the world. It is well known that SARS-CoV-2 infects everyone across all age groups, but older age groups tend to have severe symptoms compared with younger groups.

Recent studies published by Andrew G Letizia and team look at subsequent infection risks for SARS-CoV-2 in healthy young adults who may have had previous anti-spike IgG antibodies.

Despite the progress in vaccination, there is still a need for Indiato augment its testing capabilities by using on-the-spot antigen testing kits. In countries like New Zealand, Australia, Taiwan and Singapore, testing was rolled out rapidly and in a widespread fashion.

Several governments and researchers have highlighted the advantages of herd immunity and mass vaccination as potential strategies to tackle th

With the launch of two vaccines for COVID-19 in India, we are now geared up for vaccinating the population at large.

In early April 2020, Future Medicine published an article about the potential use of sofosbuvir for COVID-19 (SARS-CoV-2) (https://futuremedicineindia.com/repurposed-drugs-to-combat-covid-19/) due…

The outbreak of SARS-CoV-2 (COVID-19) has made us all think critically about indoor air quality in hospitals as this has an impact on the core functioning of healthcare systems.

We have seen several reports of reinfections in which an individual has been subjected to SARS-CoV-2 infection more than once.

India has now become the leading country in terms of COVID-19 spread, reporting the highest daily increases in infections anywhere the world. Present diagnostics in the country mainly rely on polymerase chain reaction (PCR), supplemented by recently introduced antigen detection kits.

The viral entry into human cells is the most important step for COVID-19 to manifest as an illness. SARS-CoV-2 initiates its entry into the human cell by binding to the angiotensin-converting enzyme receptor (ACE-2) on its surface.